-LCB-_-LRB-
The_DT
value_NN
of_IN
the_DT
clinical_JJ
test_NN
of_IN
glucocorticoid_NN
receptors_NNS
of_IN
peripheral_JJ
blood_NN
leukocytes_NNS
in_IN
patients_NNS
with_IN
chronic_JJ
pulmonary_JJ
heart_NN
disease_NN
-RCB-_-RRB-

In_IN
order_NN
to_TO
inquire_VB
into_IN
the_DT
functional_JJ
state_NN
of_IN
adrenal_JJ
cortex_NN
in_IN
patients_NNS
with_IN
pulmonary_JJ
heart_NN
disease_NN
,_,
the_DT
number_NN
of_IN
glucocorticoid_NN
receptors_NNS
-LRB-_-LRB-
GCR_NN
-RRB-_-RRB-
of_IN
peripheral_JJ
blood_NN
leukocytes_NNS
in_IN
patients_NNS
with_IN
chronic_JJ
pulmonary_JJ
heart_NN
disease_NN
was_VBD
determined_VBN
with_IN
radioligand-binding_JJ
assay_NN
and_CC
the_DT
corresponding_JJ
plasma_NN
cortisol_NN
levels_NNS
were_VBD
assessed_VBN
with_IN
radioimmune_JJ
assays_NNS
._.

The_DT
results_NNS
showed_VBD
that_IN
the_DT
number_NN
of_IN
GCR_NN
in_IN
the_DT
patients_NNS
was_VBD
significantly_RB
reduced_VBN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
and_CC
it_PRP
was_VBD
increased_VBN
when_WRB
their_PRP$
health_NN
state_NN
was_VBD
improved_VBN
._.

However_RB
,_,
it_PRP
was_VBD
still_RB
lower_JJR
than_IN
that_DT
in_IN
healthy_JJ
subjects_NNS
-LRB-_-LRB-
P_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
._.

The_DT
number_NN
of_IN
GCR_NN
in_IN
the_DT
patients_NNS
was_VBD
greatly_RB
increased_VBN
when_WRB
these_DT
patients_NNS
were_VBD
treated_VBN
with_IN
oxygen_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.01_CD
-RRB-_-RRB-
._.

No_DT
difference_NN
in_IN
plasma_NN
cortisol_NN
was_VBD
found_VBN
between_IN
the_DT
patients_NNS
and_CC
the_DT
healthy_JJ
subjects_NNS
-LRB-_-LRB-
P_NN
&gt;_JJR
0.05_CD
-RRB-_-RRB-
._.

These_DT
results_NNS
indicate_VBP
that_IN
the_DT
function_NN
of_IN
adrenal_JJ
cortex_NN
may_MD
be_VB
improved_VBN
by_IN
the_DT
compensation_NN
mechanism_NN
of_IN
the_DT
patients_NNS
,_,
but_CC
the_DT
lower_JJR
GCR_NN
number_NN
was_VBD
the_DT
result_NN
of_IN
lacking_VBG
of_IN
oxygen_NN
in_IN
the_DT
patients_NNS
._.

The_DT
number_NN
of_IN
GCR_NN
may_MD
be_VB
improved_VBN
by_IN
inhalation_NN
of_IN
oxygen_NN
._.

Therefore_RB
oxygen_NN
therapy_NN
is_VBZ
helpful_JJ
in_IN
raising_VBG
the_DT
activity_NN
of_IN
glucocorticoid_NN
receptors_NNS
and_CC
controlling_VBG
the_DT
development_NN
of_IN
the_DT
disease_NN
._.

